JA
Jazz Pharmaceuticals plc
JAZZ · NASDAQ
$240.83 -2.42% (-$5.98)
1M -1.00%
Market Cap $15.4B
P/E Ratio 16.42x
Div. Yield -
ROE 21.37%
Bulios Fair Price
$245.5
1.9% upside
Current Price
$240.83
Undervalued Fair Value Overvalued
According to Bulios Fair Price, JAZZ is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
8/9Valuation
73 /100
Cheap P/FCF 10.01x
P/E 16.42x
P/B 3.22x
Growth
68 /100
Growing Book val. growth 11.86%
Rev. growth 5.26%
FCF growth 18.79%
Profitability
100 /100
Strong Op. margin 31.05%
Gross margin 84.67%
FCF margin 33.52%
Quality
84 /100
Excellent ROA 8.49%
ROIC 18.70%
Asset turnover 0.42x
Debt
64 /100
Moderate Int. coverage 4.74x
Debt/Equity 0.92x
Net debt/EBITDA 1.89x
Stability
39 /100
Moderate EPS volatility 219.02%
Beta 0.32x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about JAZZ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Renee D. Gala
Employees
2,890
Headquarters
Dublin
Upcoming events
04 NOV
Earnings
Upcoming earnings report